146 related articles for article (PubMed ID: 38351252)
1. Diagnostic approach with Z-score mapping to reduce artifacts caused by cerebral atrophy in regional CBF assessment of mild cognitive impairment (MCI) and Alzheimer's disease by [
Odano I; Maeyatsu F; Hosoya T; Asari M; Oba K; Taki Y
Jpn J Radiol; 2024 May; 42(5):508-518. PubMed ID: 38351252
[TBL] [Abstract][Full Text] [Related]
2. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
[TBL] [Abstract][Full Text] [Related]
4. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
[TBL] [Abstract][Full Text] [Related]
5. The need of appropriate brain SPECT templates for SPM comparisons.
Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
[TBL] [Abstract][Full Text] [Related]
6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
7. [Advance prediction of Mild Cognitive Impairment (MCI) using (99m)Tc-ECD SPECT brain blood flow imaging].
Kawasaki Y
Nihon Ronen Igakkai Zasshi; 2008 Mar; 45(2):202-12. PubMed ID: 18441495
[TBL] [Abstract][Full Text] [Related]
8. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry.
Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H
Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422
[TBL] [Abstract][Full Text] [Related]
9. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of MCI with Lewy bodies and MCI due to Alzheimer's disease by visual assessment of occipital hypoperfusion on SPECT images.
Nakata T; Shimada K; Iba A; Oda H; Terashima A; Koide Y; Kawasaki R; Yamada T; Ishii K
Jpn J Radiol; 2024 Mar; 42(3):308-318. PubMed ID: 37861956
[TBL] [Abstract][Full Text] [Related]
13. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
[TBL] [Abstract][Full Text] [Related]
14. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of brain perfusion single-photon emission tomography images using an easy Zscore imaging system for early diagnosis of Alzheimer's disease].
Wang S; Qi Y; Jiang Y; Chi X; Huang K; Ruan C; Yang X; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1093-1100. PubMed ID: 34308862
[TBL] [Abstract][Full Text] [Related]
16. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
17. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
[TBL] [Abstract][Full Text] [Related]
18. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
19. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction.
Matsuda H; Kanetaka H; Ohnishi T; Asada T; Imabayashi E; Nakano S; Katoh A; Tanaka F
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1502-5. PubMed ID: 12397471
[TBL] [Abstract][Full Text] [Related]
20. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
